Table 5

Short-term neonatal clinical outcomes

Clinical outcomesAll infants (n=37)
IRDS8 (21.6)
Surfactant therapy7 (18.9)
Respiratory support <72 hours28 (75.7)
 Nasal cannula0
 CPAP/High flow23 (62.2)
 Invasive ventilation5 (13.5)
Inotropes <72 hours2 (5.4)
PDA diagnosed7 (18.9)
Treated5 (13.5)
NEC ≥stage 23 (8.1)
Late onset infection11 (29.7)
Hyperbilirubinaemia
 Phototherapy35 (94.6)
 Exchange transfusion0
Erythrocyte transfusion7 (18.9)
Polycythaemia3 (8.1)
IVH5 (13.5)
 Grade 12 (5.4)
 Grade 21 (2.7)
 Grade 32 (5.4)
 Venous infarction1 (2.7)
Ventricular dilatation1 (2.7)
ROP4 (10.8)
 Grades 1–24 (10.8)
 Grades 3–40
BPD3 (8.1)
 Mild0
 Moderate0
 Severe3 (8.1)
  • Data are presented as n (%).

  • BPD, bronchopulmonary dysplasia; CPAP, continuous positive airway pressure; IRDS, infant respiratory distress syndrome; IVH, intraventricular haemorrhage; NEC, necrotising enterocolitis; PDA, persistent ductus arteriosus; ROP, retinopathy of prematurity.